As expected, sotatercept was associated with a modest increase in hemoglobin (Hb) in RCTs enrolling patients with PAH, with the mean Hb rising by 1.3 mg/dL [2]. The gene discussed is GSTM1; the disease is pulmonary arterial hypertension.